We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+0.57%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$17.3B
AUM Growth
+$91.5M
Cap. Flow
+$336M
Cap. Flow %
1.94%
Top 10 Hldgs %
59.81%
Holding
1,066
New
76
Increased
460
Reduced
487
Closed
41

Top Buys

Rank Stock Value
1
HESM icon
Hess Midstream
HESM
+$99M
2
PAA icon
Plains All American Pipeline
PAA
+$94.7M
3
EPD icon
Enterprise Products Partners
EPD
+$41.7M
4
WES icon
Western Midstream Partners
WES
+$32.4M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$26M

Top Sells

Rank Stock Value
1
FNDX icon
Schwab Fundamental US Large Company Index ETF
FNDX
+$32.7M
2
ET icon
Energy Transfer Partners
ET
+$18.7M
3
FNDA icon
Schwab Fundamental US Small Company Index ETF
FNDA
+$17M
4
CCJ icon
Cameco
CCJ
+$14.7M
5
CQP icon
Cheniere Energy
CQP
+$13.1M

Sector Composition

Rank Sector Weight
1 Energy 68.28%
2 Technology 4.29%
3 Financials 3.4%
4 Consumer Discretionary 2.95%
5 Materials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLD icon
1051
Prologis
PLD
$138B
– –
-3,809
Closed -$426K
PLL
1052
DELISTED
Piedmont Lithium
PLL
– –
-33,637
Closed -$212K
PLRX icon
1053
Pliant Therapeutics
PLRX
$67.5M
– –
-45,261
Closed -$61.1K
PROK icon
1054
ProKidney
PROK
$308M
– –
-95,182
Closed -$83.4K
RIGL icon
1055
Rigel Pharmaceuticals
RIGL
$680M
– –
-13,100
Closed -$236K
RNAC icon
1056
Cartesian Therapeutics
RNAC
$232M
– –
-19,392
Closed -$256K
SLRN
1057
DELISTED
ACELYRIN
SLRN
– –
-74,640
Closed -$184K
STRO icon
1058
Sutro Biopharma
STRO
$379M
– –
-6,127
Closed -$39.9K
SVRA icon
1059
Savara
SVRA
$1.13B
– –
-115,752
Closed -$321K
VRNA
1060
DELISTED
Verona Pharma
VRNA
– –
-60,180
Closed -$3.82M
WOLF icon
1061
Wolfspeed
WOLF
$1.2B
– –
-242,648
Closed -$743K
ZNTL icon
1062
Zentalis Pharmaceuticals
ZNTL
$308M
– –
-55,033
Closed -$87.5K
AVBP icon
1063
ArriVent BioPharma
AVBP
$1.48B
– –
-25,167
Closed -$465K
KYTX icon
1064
Kyverna Therapeutics
KYTX
$450M
– –
-32,126
Closed -$62K
FBMS
1065
DELISTED
The First Bancshares, Inc.
FBMS
– –
-10,330
Closed -$349K
ML
1066
DELISTED
MoneyLion Inc.
ML
– –
-4,130
Closed -$357K
39 40 41 42
43

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, ALPS Advisors held 1,066 positions worth $17.3B, up 0.53% from $17.2B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

ALPS Advisors's Q2 2025 filing shows 76 new, 460 increased, 487 reduced and 41 closed positions. Its largest new stake was ALPS Dynamic US Dividend Advantage ETF: 231,612 shares worth $13.4M. The largest sale was Schwab Fundamental US Large Company Index ETF, an estimated $32.7M.

By sector, the portfolio is most concentrated in Energy at 68% of assets, down from 70% a quarter earlier, followed by Technology and Financials.

  • ALPS Advisors's largest Q2 2025 buy was ALPS Dynamic US Dividend Advantage ETF: 231,612 shares worth $13.4M.
  • ALPS Advisors added most to Hess Midstream in Q2 2025, an estimated $99M increase.
  • ALPS Advisors's biggest Q2 2025 reduction was Energy Transfer Partners, cutting an estimated $18.7M.
  • ALPS Advisors fully exited Schwab Fundamental US Large Company Index ETF in Q2 2025, selling an estimated $32.7M.
  • ALPS Advisors's ten largest holdings make up 60% of its $17.3B portfolio in Q2 2025.
  • ALPS Advisors opened 76 new positions and closed 41 in Q2 2025.
  • ALPS Advisors's portfolio value rose 0.53% quarter-over-quarter to $17.3B.

Based on ALPS Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.